Search results
Results from the WOW.Com Content Network
On Wednesday, ImmunityBio, Inc. (NASDAQ:IBRX) released progress in its ongoing FDA discussions regarding three areas of its clinical development pipeline in non-muscle invasive bladder cancer ...
The stock is up more than 50% so far in 2024, and until Tuesday, the market cap had been above $860 billion. The company's valuation sank by $100 billion Wednesday morning, reaching $750 billion.
Tempest Therapeutics Inc. (NASDAQ:TPST) stock is trading higher on Thursday, with a strong session volume of over 23 million as per data from Benzinga Pro. The company entered into an agreement ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
StemCell Technologies Canada Inc. (formerly known as StemCell Technologies Inc.) is a Canadian biotechnology company that develops and manufactures cell culture media and cell separation technologies for use in stem cell, immunology, and cancer research. [1] [2]
Chimerix stock is trading higher on a strong session volume of 4.31 million, compared to an ave ... CMRX) announced that, following extensive dialogue with the FDA, the company plans to submit a ...
[10] [11] Lo and Prenetics are working together to create a new company, Insighta, that will focus on their cancer detection work. [12] The early detection cancer test, Presight, will begin clinical trials in 2024. [12] The company claims that by 2027 patients will be able to test for more than 10 types of cancer with a single blood test. [13]
Can-Fite BioPharma (NYSEMKT:CANF) is certainly a stock to keep an eye on this week. Shares of CANF stock opened higher by 16.7% on Wednesday after the company reported positive results from a ...